Baroness Masham of Ilton – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Baroness Masham of Ilton on 2016-02-01.
To ask Her Majesty’s Government what specific steps they will take to ensure that the review of the statutory scheme for branded medicines takes into account the specificities of medicines derived from human blood plasma, in the light of the Council of Europe resolution on principles concerning human normal immunoglobulin therapies for immunodeficiency and other diseases (CM/RES(2015)2).
Lord Prior of Brampton
We are continuing to consider carefully all the consultation responses including those that refer to blood plasma products. It is important we get these changes right for patients, the National Health Service and industry. We want to look in particular at the impact on small and medium sized businesses, while securing the medicines patients need at a cost which the NHS can afford.
